were separated and the aqueous phase was extracted with light
petroleum (2 × 200 cm3). The organic phases were combined,
washed with water (200 cm3) and saturated NaHCO3 solution
(2 × 200 cm3), dried (CaCl2) and then filtered through a plug
of silica. The filtrate was concentrated in vacuo to yield a
yellow oil (6.0 g). The oil (min. 70% pure by NMR) could
not be purified by flash chromatography, and was used with-
out further purification. dH (CDCl3, 300.1 MHz) (0.89, 6H, t,
H4), 131.0 (C, ortho-Ar para to C7H15), 132.3 (C, Ar, Ar para to
ArCH3), 133.5 (CH, meta-Ar), 135.2 (br m, CD due to exchange,
imidazolium C2), 135.8 (CH, Ar ortho to C7H15), 139.2 (C, Ar,
para to ArH), 140.9 (C, Ar adjacent to ArCH3) and 145.4 (C,
Ar, ortho to C7H15).
Synthesis of the silver complexes
4·2PF6. Ag2O (356 mg, 1.5 mmol) was added to a solution
of the cyclophane salt I·2PF6 (325 mg, 0.51 mmol) in
acetonitrile (50 cm3). The mixture was heated at 50 °C for
24 h under the exclusion of light. A clear solution with
some black suspension was obtained. The black suspension
was filtered off, the filtrate was poured into water (50 cm3),
and the resulting white powder was collected by filtration.
Recrystallisation of the powder from acetonitrile yielded
colourless crystals (139 mg, 43%) (Found: C, 44.77; H, 3.79;
N, 10.56. C44H40Ag2F12N8P2·CH3CN requires C, 45.01; H, 3.53;
N, 10.27%). Crystals suitable for X-ray diffraction studies were
grown by layering a concentrated solution of the complex in
acetonitrile with neat diethyl ether.
3JCH ,CH = 7.0 Hz, 2 × –CH2CH3), 1.20–1.42 and 1.50–1.61 (20H,
2
2 × m, 32 × –CH2(CH2)5CH3), 2.56 (4H, t, 3JCH ,CH = 7.9 Hz, 4 ×
2
–CH2CH2(CH2)4CH3), 4.64 (4H, s, 2 × –CH2Br)2and 7.12 (2H,
s, 2 × ArH); dC (CDCl3, 75.5 MHz) 14.1 (CH3), 22.7, 29.1, 29.7,
30.6, 31.0, 31.2, 31.6, 31.8, 32.3 (CH2), 131.8 (Ar CH), 133.6 and
142.3 (Ar C); m/z (EI) 458.1196 (M) (requires 458.1184).
1,2-Bis(imidazol-1-yl)-4,5-diheptylbenzene. A solution of the
crude 1,2-bis(bromomethyl)-4,5-diheptylbenzene (6.0 g) and
imidazole (9.6 g, 140 mmol) in thf (200 cm3) was heated at
reflux for 2 h. Powdered potassium hydroxide (2.6 g, 39 mmol)
was added to the solution and refluxing was continued over-
night. The mixture was cooled and then concentrated in vacuo.
The residue was mixed with water (200 cm3) and then warmed
on a steam bath for 10 min. The resulting oil was separated and
dissolved in diethyl ether (100 cm3). The ethereal phase was
washed with water (100 cm3) and then concentrated in vacuo. The
residue was purified by rapid silica filtration (dry-packing onto
silica, washing successively with dichloromethane and diethyl
ether, then elution of the desired compound with methanol).
The residue was then recrystallised from wet light petroleum
(50 cm3) to afford the product as a colourless powder (2.3 g)
(Found: C, 76.67; H, 10.11; N, 12.42. C28H42N4.·1/3H2O requires
C, 76.32; H, 9.76; N, 12.71%); dH (CDCl3, 300.1 MHz) 0.88 (6H,
5·2PF6. A solution of the cyclophane salt III·2Br (90 mg,
0.18 mmol) and Ag2O (85 mg, 0.37 mmol) in dmf (15 cm3) was
heated at 90 °C for 24 h under the exclusion of light. A clear
solution with black suspension was obtained. The mixture was
filtered and the solvent was removed under reduced pressure.
The off-white residue was dissolved in water (5 cm3) and added
to an aqueous solution of KPF6 (67 mg, 0.36 mmol, 5 cm3 H2O).
The white precipitate that formed immediately was collected and
recrystallised from acetonitrile to yield the product as colour-
less crystals (41 mg, 39%) (Found: C, 44.14; H 3.63; N 9.33.
C44H40N8Ag2P2F12 requires C, 44.54; H, 3.40; N, 9.44%).
3
t, JCH ,CH = 6.7 Hz, 2 × –CH2CH3), 1.25–1.36 (16H, m, 2 ×
2
–CH2CH23(CH2)4CH3), 1.51 (4H, m, 2 × –CH2CH2(CH2)4CH3),
2.56 (4H, m, 2 × –CH2CH2(CH2)4CH3), 4.97 (4H, s, 2 × benzylic
CH2), 6.76 (2H, s, 2 × imidazolyl CH), 6.88 (2H, s, 2 × ArH),
7.08 (2H, s, 2 × imidazolyl CH) and 7.51 (2H, s, 2 × imidazolyl
CH); dC (CDCl3, 75.5 MHz) 14.1 (CH3), 22.6, 29.1, 29.6, 31.1,
31.7, 32.3, (CH2), 48.1 (benzylic CH2), 119.1, 129.5, 137.1
(imidazolyl CH), 130.8 (Ar CH), 130.7 and 142.1 (Ar C); m/z
(EI) 434.3398 (M) (requires 434.3409).
6·2BPh4. A mixture of Ag2O (20 mg, 86 lmol) and the cyclo-
phane salt IV·2Br (38 mg, 51 lmol) in methanol (20 cm3) was
stirred, in darkness, for ca. 2.5 h, then filtered through a short
plug of Celite. To the filtrate was added a solution of NaBPh4
(77 mg, 0.2 mmol) in methanol (5 cm3). The resulting (48 mg)
solid was collected and recrystallised from acetonitrile to yield
the product as colourless crystals (24 mg, 47%) (Found: C,
74.24; H, 7.21; N, 5.35. C126H148Ag2B2N8·H2O requires C, 74.55;
H, 7.45; N, 5.52%). Crystals suitable for X-ray diffraction stud-
ies were grown by slowly cooling a solution of the complex in
acetonitrile.
The ortho/meta-cyclophane IV·2Br. Solutions of 1,2-
bis(imidazol-1-yl)-4,5-diheptylbenzene (0.98 g, 2.2 mmol) in
acetone (30 cm3) and 1,3-bis(bromomethyl)-2,4,6-trimethyl-
benzene (0.72 g, 2.3 mmol) in acetone (30 cm3) were added
portionwise, simultaneously, to acetone (75 cm3) at reflux over
the course of 2 h. The resulting mixture was heated at reflux
for a further 2 h and was then allowed to stand overnight. The
precipitate was collected, washed with cold acetone and dried to
yield a white powder (1.5 g). The powder was recrystallised from
acetone–water to give IV·2Br as a colourless solid (0.90 g, 54%)
(Found: C, 61.41; H, 7.84; N, 7.18. C39H56N4Br2·H2O requires C,
61.74; H, 7.71; N, 7.38%); dH (CD3OD, 500.1 MHz) 0.91 (12H,
7. A mixture of the cyclophane salt II·2Br (267 mg, 0.46 mmol)
and Ag2O (105 mg, 0.46 mmol) in dmso (15 cm3) was heated at
80 °C for 4 days under the exclusion of light. A clear solution
with black suspension was obtained. The mixture was filtered
and concentrated under reduced pressure. Recrystallisation
of the residue from dmf yielded a grey powder (75 mg, 43%)
(Found: C, 41.97; H, 3.91; N, 7.03. C28H32N4Ag2Br2 requires C,
42.03; H, 4.03; N, 7.00%). Attempts to grow crystals suitable for
X-ray diffraction studies from a concentrated solution of 7 in
d6-dmso–acetonitrile yielded crystals of 8.
3
t, JCH ,CH = 6.9 Hz, 2 × –CH2CH3), 1.29–1.37 and 1.37–1.48
2
(19H, 2 ×3 m, 2 × –CH2CH2(CH2)4CH3 + ArCH3 para to ArH),
1.65 (4H, m, 2 × –CH2CH2(CH2)4CH3), 2.56 (6H, s, 2 × ArCH3
ortho to ArH), 2.75 (4H, m, 2 × –CH2CH2(CH2)4CH3), 5.21
Structure determinations
2
(2H, br d, JCHH,CHH = 14.8 Hz, 2 × ortho-benzylic CHH), 5.51
Full spheres of ‘low’-temperature CCD area-detector diffracto-
meter data were measured (Bruker AXS instrument, x-scans;
monochromatic Mo-Ka radiation, k = 0.71073 Å, T ca. 153 K)
yielding Nt(otal) reflections, these merging to N unique (Rint cited)
after ‘empirical’/multiscan absorption correction (proprietary
software), No with F > 4r(F) considered ‘observed’ and used
in the full matrix least squares refinements, refining anisotropic
displacement parameter forms for the non-hydrogen atoms,
(x,y,z,Uiso)H being constrained at estimates. Conventional
residuals R, Rw (weights: (r2(F) + 0.000 nwF2)−1) are quoted
at convergence; neutral atom complex scattering factors were
employed within the context of the Xtal 3.7 program system.52
Pertinent results are given below and in the Tables and Figures,
(2H, d, 2JCHH,CHH = 15.2 Hz, 2 × meta-benzylic CHH), 5.60 (2H,
2JCHH,CHH = 15.2 Hz, 2 × meta-benzylic CHH), 5.95 (2H, br d,
2JCHH,CHH = 14.8 Hz, 2 × ortho-benzylic CHH), 7.30 (1H, s, ArH
ortho to ArCH3), 7.67 (2H, s, 2 × ArH ortho to –C7H15), 7.68
3
(2H, d, JH4,H5 = 2 Hz, 2 × imidazolium H5, near ortho-arene)
3
and 7.87 (4H, d, JH4,H5 = 2 Hz, 2 × imidazolium H4) [Note:
1
imidazolium H2 not seen in H NMR spectrum due to rapid
H–D exchange]; dC (CD3OD, 125.8 MHz) 14.4 (–CH2CH3), 15.7
(ArCH3 para to ArH), 20.1 (ArCH3 ortho to ArH), 23.7 (CH2),
30.3 (CH2), 30.8 (CH2) 32.5 (CH2), 33.0 (CH2), 33.3 (CH2), 49.6
(meta-benzylic CH2), 50.5 (ortho-benzylic CH2), 122.2 (br, CH,
imidazolium H5, near ortho-arene), 126.3 (CH, imidazolium
3 7 6 2
D a l t o n T r a n s . , 2 0 0 4 , 3 7 5 6 – 3 7 6 4